HCL Technologies is currently trading at Rs. 1416.30, up by 26.60 points or 1.91% from its previous closing of Rs. 1389.70 on the BSE.
The scrip opened at Rs. 1400.00 and has touched a high and low of Rs. 1417.00 and Rs. 1398.30 respectively. So far 21754 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1588.65 on 28-Feb-2014 and a 52 week low of Rs. 716.70 on 17-May-2013.
Last one week high and low of the scrip stood at Rs. 1417.00 and Rs. 1313.70 respectively. The current market cap of the company is Rs. 98507.58 crore.
The promoters holding in the company stood at 61.69 % while Institutions and Non-Institutions held 32.28 % and 6.03 % respectively.
HCL Technologies, a leading IT services provider, has been selected by Novartis, one of the world’s leading healthcare companies, to provide global infrastructure management services. Novartis will leverage HCL’s global delivery model for remote infrastructure management services across its entire data centre landscape, covering more than 70 countries across six continents.
This deal marks an important infrastructure outsourcing contract in HCL’s DACH region, and strengthens the company’s global expertise in infrastructure management within the pharmaceutical sector. HCL is now managing the infrastructure environment of four of the top seven pharmaceutical companies worldwide.
HCL Technologies is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses. HCL leverages its extensive global offshore infrastructure and network of offices in 31countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare & Life sciences.